Weigao Controlling Shareholder Lifts Stake, Signaling Confidence in China’s Medical Device Growth

Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has shared an update.

Shandong Weigao Group Medical Polymer Company Limited announced that its controlling shareholder, Weigao Holding Company Limited, has increased its stake in the company by purchasing 3,552,800 H shares on the open market on 13 and 14 May 2026. Following the transaction, Weigao Holding now owns about 46.51% of the issued H shares and 46.02% of the company’s total share capital, signaling strong confidence in the group’s long-term value and the growth prospects of China’s medical device market.

The move underscores the controlling shareholder’s commitment to the company’s future development and may be viewed as a supportive signal for other investors amid expectations of continued expansion in the domestic healthcare sector. Weigao Holding has also indicated that it may further increase its shareholding when appropriate, while the company has cautioned shareholders and potential investors to exercise care when dealing in its securities.

The most recent analyst rating on (HK:1066) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Company Limited is a PRC-based medical device manufacturer listed in Hong Kong, focused on medical polymer products and serving China’s growing healthcare market. The group targets the expanding domestic medical devices sector, positioning itself as a key player amid rising demand for advanced medical consumables and equipment.

Average Trading Volume: 22,780,265

Technical Sentiment Signal: Sell

Current Market Cap: HK$15.83B

For an in-depth examination of 1066 stock, go to TipRanks’ Overview page.